Instituto de Información e Investigación en Salud Mental A. C. Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2018
NCT04430556
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Instituto de Información e Investigación en Salud Mental A. C.

Active Ingredients

Drugs in Phase 2 Trials (1)

l-glutamine (1 trial)

Drugs in Other Trials (1)

sertraline (zoloft) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 2)

Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2